Log In
BCIQ
Print this Print this
 

SAR501788

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionPeripheral benzodiazepine receptor (PBR) ligand
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationNerve damage
Indication DetailsTreat sensory and motor neuron degeneration
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today